Three Scenarios for the Scaling up Potential of LPBI Group’s BioMed e-Series: Lights on Intellectual Property Growth Capacity and the Business Potential of the Venture
Author: Aviva Lev-Ari, PhD, RN
From: Aviva Lev-Ari <avivalev-ari@alum.berkeley.edu>
Date: October 20, 2018 at 10:36:21 AM EDT
To: Gail Thornton <gailsthornton@yahoo.com>, “Dr. Larry Bernstein” <larry.bernstein@gmail.com>, Stephen J Williams <sjwilliamspa@comcast.net>
Cc: Marcus Feldman <mfeldman@stanford.edu>, rmandahl@gmail.com, Justin MDMEPhD <jdpmdphd@gmail.com>, Tilda Barliya <tildabarliya@gmail.com>, “Dr. Irina Robu, PhD” <irina.stefania@gmail.com>, “Dr. Raphael Nir” <rnir@sbhsciences.com>, “Dr. Dror Nir” <drornir0305@gmail.com>, Dee Sag <demet.sag@gmail.com>, Sudipta Saha <sudiptasaha1977@gmail.com>
Subject: Re: Dr. Laura Carfang from SurvivingBreastCancer.org interested in your Voices project
Dr. Larry, Dr. Williams, Gail
I wish to thank Dr. Williams for exposing to SurvivingBreastCancer.org
Our Series E: Parient-centered Medicine, Volume One: Voices of Patients, an e-Book on patients personal experiences with invasive surgical procedures, chiefly, cancerous organ excision and open heart surgery.
This Volume one is unique and please all read again the Preface, Introduction, Summary and Epilogue. Read in the follwoing link:
and
Co-Editors: Dr. Larry H. Bernstein and Gail Thornton
As Editor-in-Chief, I made the selection of the editors and envisioned the following unique features of this e-book:
- Commissioned Gail to conduct interviews with Patients and to author articles that provide primary patients accounts. One article of Gail is on a cardiac patient, the rest on several cancer types, non on Breast Cancer
- Gail, as Volume Co-Editors suggested to conduct interviews with Hospital CEOs around the Globe, I.e., Singapore, Switzerland, US: CA, NJ
- Commissioned Dr. Larry to contribute articles on “The MD as a Cancer Patient”
- Identified another “MD as a cancer patient”, Finding My Voice: A Laryngectomee’s Story
- Identified two authors, for cardiac patients experience, one with open heart surgery, the other about a cardiac medical device in usage
As such, Series E: Volume One is a very distinctive e-Book. Gail Thornton and myself discussed marketing the e-Book in Cancer Treatment Centers in the US. The e-Book is priced for patients as e-readers ($49, 824 pages vs $75 or $115 for volumes of 2,000 – 3,000 pages or more)
I personally, planned this volume to be an e-Book widely marketed and read by the public at large. The other 15 volumes are of interest to the public, they are primarily for the Heath Care sector professionals, policy makers in Heath Care, Science and Research Administrators, Scientists, the entire GLOBAL and American Medical community.
Our BioMed e-Series Plan: SIXTEEN volumes to be completed in July 2019 and reach the Milestone of EXIT and ownership transfer in 12/2019 to 12/2020, time frame.
Dr. Lev-Ari gave Series E its Title and the Titles to Volume 1,2,3,4 in this e-Series. That was the case with all other four e-Series:
https://pharmaceuticalintelligence.com/biomed-e-books/
- Series A: Cardiovascular, six volumes,
Content Consultant, Dr. J.D. Pearlman
- Series B: Genomics, two volumes,
Content Consultant, Prof. M.W. Feldman, Stanford University
- Series C: Cancer, two volumes,
Content Consultant, Dr. L.H. Bernstein
- Series D: Metabolomics, Immunology, Infectious Diseases,
Content Consultant, Dr. L.H. Bernstein
- Series E: Patient-centered Medicine, four volumes
Content Consultant, Dr. L.H. Bernstein
This e-mail is about an organization, I.e., SurvivingBreastCancer.org expressing interest to support
—–>>> A NEW e-BOOK, in Series E, Volume One: Patient Voices
To focus on the VOICES of Survivors of Breast Cancer as 2nd Edition to Volume One.
This volume, if produced, will be #17.
- The initial 16-Volume BioMed Series did not plan on 2nd Editions to each Volume.
In light of SBC INTEREST, I see three Scenarios:
Scenario #1 limited LPBI Group involvement beyond LPBI Group Intellectual Property:
– SurvivingBreastCancer.org (SBC) is given by fiat for being .org LPBI Group’s permission to use our methods in e-Publishing. They choose the Editor and they produce by their Editor and writers of their choice a volume IN THE IMAGE of Series E, Volume One 1st Edition.
Here we own two IP assets
1.1 MIRROR IMAGE OF THE e-Table of Contents (eTOCs) of Volume One 1st Edition
1.2 The Curation methodology and all Formats, as perfected in 16-volume BioMed e-Series
Scenario #2 more involvement by LPBI Group
2.1 All of mentioned in #1 Scenarios
and
2.2. Dr. Williams provides SBC with a Bibliography in descending date of publishing of ALL Breast Cancer articles in the Archive of pharmaceuticalintelligence.com – all 5,400 articles in the Journal Archive are 100% IP of LPBI Group.
Scenario #3 LPBI Group becomes a BUSINESS PARTNER for SBC on the production of LPBI Group’s BioMed e-Series, Series E,
Volume One 2nd Edition on VOICES of Patients of Breast Cancer Survivors
Other Options using LPBI Group Intellectual Property – very attractive proposition for potential transfer of ownership, aka, EXIT
- eTOCs of Series E, Volume One, 1st Edition
- The methodology of Curation and all Formats
- Bibliography in descending date of Publication of articles on the CANCER TYPE from LPBI Group’s Archive of pharmaceuticalintelligence.com
Collaboration and Partnership with Patient Advocacy Foundations to support the following: Scaling up “Digital Library” Options on VOICES of Patients by TYPE of CANCER
- Volume One 3rd Edition on VOICES of Patients of Prostate Cancer Survivors
- Volume One 4th Edition on VOICES of Patients of Lymphomas and Leukemias
- Volume One 5th Edition on VOICES of Patients of Lung Cancer
- Volume One 6th Edition on VOICES of Patients of Brain, Head and Neck Cancers
- Volume One 7th Edition on VOICES of Patients of Pancreas, Liver and Biliary System Cancers
- Volume One 8th Edition on VOICES of Patients of GI and Colonrectal
- Volume One 9th Edition on VOICES of Patients of Skin Cancers
- Volume One 10th Edition on VOICES of Patients of Myelomas (Bone), Sarcomas and rare
- Connective tissue cancers
- Volume One 11th Edition on VOICES of Patients of Kidney and Bladder Cancers and the GU system
- Volume One 12th Edition on VOICES of Patients of Reproductive Organ Cancers: Ovarian, Cervical and Testicular
BioMed e-Series 16 volumes could have TEN Editions each, Aviva can specify all these e-Book Titles on behalf of a Publisher(s).
- 160 new titles. For a PUBLISHER, this is a gold mine.
SAME, as these Options for NEW Editions for Series E, Volume One, LPBI Group will draft Options for NEW Editions for
- Series A – six volume times TEN Editions per Volume
- Series B – two volumes times TEN Editions per Volume
- Series C – two volumes times TEN Editions per Volume
- Series D – three volume times TEN Editions per Volume
- Series B – four volumes times TEN Editions per Volume
Thank you
Aviva Lev-Ari, PhD, RN
Editor-in-Chief, BioMed e-Series
http://PharmaceuticalIntelligence.com
Director & Founder
Leaders in Pharmaceutical Business Intelligence (LPBI) Group
Leave a Reply